Regular biography
Dr. Li Hoi Yeung is an Associate Professor Director (Special Projects) at the School of Biological Sciences, Nanyang Technological University. His research integrates cancer biology, drug discovery from natural compounds, and advanced microscopy imaging. He specializes in developing targeted cancer therapies through synthetic lethality mechanisms using bioactive natural products. Dr. Li has attracted substantial industrial funding and established multiple successful collaborations with biotech companies, translating laboratory innovations into potential medical solutions. His entrepreneurial achievements include founding NYB-AI, an AI-focused drug discovery startup selected by the Nvidia Ignition AI program. With over 50 peer-reviewed publications and multiple patents, Dr. Li demonstrates a sustained commitment to bridging academia and industry, significantly advancing translational biomedical research and innovation.
Scholar-generated biography
Hoi-Yeung Li is a researcher at Nanyang Technological University with expertise in AI Drug Discovery, Genomic instability, Cancer Biology, and Imaging Techniques. Their work explores the molecular mechanisms underlying cancer progression, particularly focusing on genomic instability and its role in tumor development. Li's research also investigates the regulation of chromosome segregation and mitotic processes, with an emphasis on the function of proteins such as survivin and RCC1. Additionally, they utilize advanced imaging techniques to study cellular dynamics and develop novel therapeutic strategies for cancer treatment. Their contributions span from molecular biology to drug discovery, highlighting the interplay between genomic instability and cancer biology.